Novel pyridine-thiazolidinone-triazole hybrid glycosides targeting EGFR and CDK-2: Design, synthesis, anticancer evaluation, and molecular docking simulation
Asmaa F. Kassem, Mohamed A. Omar, Eman S. Nossier, Hanem M. Awad, Wael A. El‐Sayed
Topics & Concepts
ChemistryCyclin-dependent kinaseErlotinibKinaseStereochemistryCell cyclePharmacologyBiochemistryApoptosisEpidermal growth factor receptorReceptorMedicineCancer therapeutics and mechanismsChronic Lymphocytic Leukemia ResearchCancer Mechanisms and Therapy